SCHEMBL8358674

SCHEMBL8358674

O=C1/C(=N\Cc2cc(F)cc(F)c2)c2ccccc2N1c1ccc(O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H3 Q13133 3/20 0.44
KMT2A Q03164 4/20 0.42
MEN1 O00255 1/20 0.42
ACE P12821 3/20 0.41
MAPT P10636 5/20 0.40
NPSR1 Q6W5P4 2/20 0.40
GALR3 O60755 3/20 0.40
HTR4 Q13639 1/20 0.40
ALDH1A1 P00352 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
LMNA P02545 1/20 0.38
CES2 O00748 1/20 0.37
BCHE P06276 1/20 0.37
GAA P10253 1/20 0.37
CES1 P23141 1/20 0.37
ESR1 P03372 2/20 0.36
ESR2 Q92731 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5357199 0.82 GALR3 (0.53) NR1H3KMT2AMEN1ACEMAPT
SCHEMBL5357195 0.82 GALR3 (0.53) NR1H3KMT2AMEN1ACEMAPT
SCHEMBL12942336 0.77 KMT2A (0.52) KMT2AMEN1ACEMAPTNPSR1
SCHEMBL8356127 0.73 GALR3 (0.46) NR1H3GALR3HTR4ESR1ESR2
SCHEMBL8410768 0.72 KMT2A (0.50) NR1H3KMT2AMEN1ACEMAPT
SCHEMBL8226920 0.72 KMT2A (0.52) KMT2AMEN1ACEMAPTNPSR1
SCHEMBL8356489 0.71 GALR3 (0.52) NR1H3GALR3HTR4
SCHEMBL8360397 0.70 GALR3 (0.50) NR1H3KMT2AMEN1ACEMAPT
SCHEMBL8406002 0.70 KMT2A (0.53) NR1H3KMT2AMEN1ACEMAPT
SCHEMBL8404173 0.70 KMT2A (0.50) KMT2AMEN1ACEMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004014854-A1 3-IMINO-2-INDOLONES FOR THE TREATMENT OF DEPRESSION AND/OR ANXIETY SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2004-02-19 WO disclosed